|
MARCKSL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.89940343640205E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.89049994839763E-09 |
| Normal-vs-Stage2 |
2.032700E-04 |
| Normal-vs-Stage3 |
3.397800E-03 |
| Normal-vs-Stage4 |
2.275800E-02 |
| Stage1-vs-Stage2 |
8.847700E-02 |
| Stage1-vs-Stage3 |
1.606390E-01 |
| Stage1-vs-Stage4 |
4.254600E-01 |
| Stage2-vs-Stage3 |
2.804100E-02 |
| Stage2-vs-Stage4 |
6.956300E-02 |
| Stage3-vs-Stage4 |
8.099200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31119999805074E-08 |
| Normal-vs-AfricanAmerican |
2.971600E-02 |
| Normal-vs-Asian |
3.002200E-03 |
| Caucasian-vs-AfricanAmerican |
6.382800E-01 |
| Caucasian-vs-Asian |
7.330000E-01 |
| AfricanAmerican-vs-Asian |
8.544000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03460000000499E-06 |
| Normal-vs-Female |
1.41970000200331E-08 |
| Male-vs-Female |
3.018200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70392999999658E-05 |
| Normal-vs-Age(41-60Yrs) |
1.5372199999919E-05 |
| Normal-vs-Age(61-80Yrs) |
1.98677999999619E-05 |
| Normal-vs-Age(81-100Yrs) |
1.950220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.657200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.272200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.876400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.530200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.776600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.125200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.082400E-02 |
| Classical-VS-Follicular |
1.606540E-04 |
| Classical-VS-Other |
2.488800E-01 |
| Classical-VS-Normal |
8.02410000000364E-07 |
| Tall-VS-Follicular |
7.81619999999927E-05 |
| Tall-VS-Other |
7.235900E-02 |
| Tall-VS-Normal |
7.875400E-01 |
| Follicular-VS-Other |
7.664400E-01 |
| Follicular-VS-Normal |
7.31570026779593E-10 |
| Other-VS-Normal |
1.361570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.2236882314437E-12 |
| Normal-vs-N1 |
2.162000E-01 |
| N0-vs-N1 |
6.136100E-03 |
|
|
